
CAS 1936529-65-5
:YKL-05-099
Description:
YKL-05-099, with the CAS number 1936529-65-5, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is known to act as a selective inhibitor of certain biological pathways, which may be relevant in the treatment of various diseases, including inflammatory conditions and certain cancers. The compound's structure typically features specific functional groups that contribute to its biological activity and selectivity. YKL-05-099 is often studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), which are crucial for understanding its efficacy and safety profile. Additionally, research may focus on its mechanism of action at the molecular level, elucidating how it interacts with target proteins or enzymes. As with many investigational compounds, ongoing studies aim to clarify its therapeutic potential, optimal dosing regimens, and any associated side effects. Overall, YKL-05-099 represents a promising candidate in the landscape of drug discovery and development.
Formula:C32H34ClN7O3
Synonyms:- 3-(2-Chloro-6-methylphenyl)-7-((2-methoxy-4-(1-methylpiperidin-4-yl)phenyl)amino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one
- Pyrimido[4,5-d]pyrimidin-2(1H)-one, 3-(2-chloro-6-methylphenyl)-3,4-dihydro-7-[[2-methoxy-4-(1-methyl-4-piperidinyl)phenyl]amino]-1-(5-methoxy-2-pyridinyl)-
- YKL-05-099
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
3-(2-Chloro-6-Methylphenyl)-7-((2-Methoxy-4-(1-Methylpiperidin-4-Yl)Phenyl)Amino)-1-(5-Methoxypyridin-2-Yl)-3,4-Dihydropyrimido[4,5-D]Pyrimidin-2(1H)-One
CAS:3-(2-Chloro-6-Methylphenyl)-7-((2-Methoxy-4-(1-Methylpiperidin-4-Yl)Phenyl)Amino)-1-(5-Methoxypyridin-2-Yl)-3,4-Dihydropyrimido[4,5-D]Pyrimidin-2(1H)-OnePurity:98%Molecular weight:600.11g/molYKL-05-099
CAS:YKL-05-099 is a salt-inducible kinase (SIK) inhibitor. It can inhibit the activity of SIK1 and SIK3.Cost-effective and quality-assured.Formula:C32H34ClN7O3Purity:99.57% - 99.66%Color and Shape:SolidMolecular weight:600.11Ref: TM-T17271
1mg74.00€5mg120.00€10mg180.00€25mg311.00€50mg464.00€100mg655.00€1mL*10mM (DMSO)159.00€YKL-05-099
CAS:YKL-05-099 is a small molecule that inhibits the activity of histone acetyltransferases and histone deacetylases. Histones are proteins involved in DNA packaging, which are important for the transcriptional regulation of genes. YKL-05-099 has been shown to inhibit leukemia cells by inhibiting the anabolic effect of all-trans retinoic acid. YKL-05-099 also modulates cellular localization, affecting the migration of hematopoietic cells to bone marrow and their proliferation. The molecule has been shown to have pharmacokinetic properties that allow it to be administered orally. It is currently being studied as a potential treatment for myelodysplastic syndrome, a condition caused by abnormal hematopoietic cells in bone marrow.
Formula:C32H34ClN7O3Purity:Min. 95%Molecular weight:600.11 g/mol



